SWM
ABBV icon

Silverlake Wealth Management’s AbbVie ABBV Stock Holding History

Silverlake Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Buy
10,027
+486
+5% +$105K 0.48% 54
2026
Q1 		$2.08M Sell
9,541
-27
-0.3% -$5.99K 0.43% 69
2025
Q4 		$2.19M Buy
9,568
+51
+0.5% +$11.6K 0.49% 56
2025
Q3 		$2.2M Sell
9,517
-81
-0.8% -$16.5K 0.53% 47
2025
Q2 		$1.78M Sell
9,598
-115
-1% -$21.4K 0.52% 58
2025
Q1 		$2.04M Buy
9,713
+801
+9% +$156K 0.77% 33
2024
Q4 		$1.58M Sell
8,912
-966
-10% -$178K 0.61% 50
2024
Q3 		$1.95M Buy
9,878
+86
+0.9% +$16.1K 0.74% 37
2024
Q2 		$1.68M Buy
9,792
+158
+2% +$26.2K 0.69% 35
2024
Q1 		$1.75M Sell
9,634
-148
-2% -$25.5K 0.89% 24
2023
Q4 		$1.52M Sell
9,782
-658
-6% -$95.9K 0.84% 26
2023
Q3 		$1.56M Buy
10,440
+174
+2% +$25.5K 0.87% 26
2023
Q2 		$1.38M Buy
10,266
+47
+0.5% +$6.89K 0.77% 27
2023
Q1 		$1.63M Sell
10,219
-250
-2% -$38.2K 0.99% 22
2022
Q4 		$1.69M Sell
10,469
-65
-0.6% -$9.97K 1.06% 22
2022
Q3 		$1.41M Buy
10,534
+300
+3% +$43K 0.96% 21
2022
Q2 		$1.57M Buy
10,234
+242
+2% +$37K 1.02% 21
2022
Q1 		$1.62M Sell
9,992
-195
-2% -$28.3K 0.93% 25
2021
Q4 		$1.38M Buy
+10,187
New +$1.2M 0.74% 34

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Silverlake Wealth Management's ABBV Position: Q2 2026 in Review

Silverlake Wealth Management increased its AbbVie (ABBV) stake by 5.1% in Q2 2026, buying an estimated $105K and bringing the position to 10,027 shares worth $2.52M. The position accounts for 0.48% of the portfolio, ranked #54.

Silverlake Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Silverlake Wealth Management held 10,027 shares of AbbVie worth $2.52M as of Q2 2026.
  • Silverlake Wealth Management bought 486 AbbVie shares in Q2 2026, an estimated $105K.
  • AbbVie made up 0.48% of Silverlake Wealth Management's portfolio in Q2 2026, its #54 holding.
  • Silverlake Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Silverlake Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.